Developer docs
API playgroundTry for free, no card

Search company profiles

Cris Pharma

Full company profile

uuid003eyu7

Namestring
Cris Pharma
Legal namestring
Cris Pharma (India) Limited
Websiteurl
crispharma.com
Company typeenum
Private
Founded yearint
1992
Descriptiontext

Cris Pharma (India) Limited is a privately held pharmaceutical contract manufacturer founded in 1992 and headquartered in Jaipur, India. The company operates a WHO-GMP certified and ISO 9001:2015 compliant manufacturing facility located in a Special Economic Zone at Selaqui, Dehradun, Uttarakhand, which has been operational since June 2006. Production is concentrated on two dosage formats: tablets (including direct compression, aqueous-coated, enteric-coated, modified/sustained release, dispersible, and bi-layer variants) and liquid orals (oral suspensions and syrups). The in-house quality control laboratory is equipped with HPLC, FTIR, dissolution apparatus, and UV spectrophotometer across physico-chemical, instrumental, microbiological, and packaging material testing sections. The company's product portfolio comprises generic formulations such as Aceclofenac + Paracetamol tablets, Acetaminophen combinations, Albendazole suspension, and Ambroxol + Salbutamol syrup.

The business model is exclusively B2B contract manufacturing (CMO), with no direct-to-consumer sales. Cris Pharma manufactures on behalf of "leading Indian pharmaceutical MNCs" for both domestic distribution and international export, with pricing handled on a quote basis tied to product specifications, volume, and regulatory requirements. Revenue is generated from contract manufacturing fees and export sales to seven countries spanning West Africa (Nigeria, Ivory Coast, Ghana), East Africa (Kenya, Uganda), Southeast Asia (Myanmar), and Central Asia (Uzbekistan). International regulatory affairs capabilities include CTD/ACTD dossier preparation and submission per the requirements of each country's Ministry of Health. Distribution is entirely direct-to-pharma-company (B2B), with no third-party logistics, retail, or e-commerce channels.

The company is managed by four directors (two at the Jaipur corporate office, one technical and one executive director at the Dehradun manufacturing facility) plus dedicated heads of Quality Control and Quality Assurance. It is part of a broader pharmaceutical group that includes Oasis Test House Limited (a leading Indian analytical services provider based in Ahmedabad and Jaipur) and Oasis Infotech (developer of OasisLIMS pharma ERP software), giving the group four decades of pharmaceutical sector experience. The company is privately held with no disclosed external investors, funding rounds, or parent company affiliation, and appears to be founder/management-owned.

Short descriptiontext

Cris Pharma (India) Limited is a private pharmaceutical contract manufacturer operating a WHO-GMP certified facility in Dehradun that produces generic tablets and liquid orals for leading Indian pharmaceutical MNCs and export markets across Africa and Asia.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersJaipur, India
HQ citystring
Jaipur
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, contract manufacturing, tablet formulations, liquid orals, generic medicines
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Contract Manufacturing
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Contract Manufacturing Services
TypeProfessional Services
Description

Cris Pharma generates revenue through contract manufacturing pharmaceutical formulations (Tablets and Liquid Orals) for domestic and export markets. The company manufactures products on contract basis for leading pharmaceutical companies, providing full-service manufacturing from process development to commercial scale production.

crispharma.com
2Export of Manufactured Drugs
TypeOne Time License
Description

Revenue from exporting manufactured pharmaceutical products to international markets including Nigeria, Myanmar, Ghana, Kenya, and Uganda. The company has regulatory approvals in multiple Francophone and African countries.

crispharma.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Cris Pharma is a pharmaceutical contract manufacturer that produces Tablets and Liquid Orals on a P2P basis for leading Indian pharmaceutical companies and international buyers. The company operates a WHO-GMP certified manufacturing facility at SEZ, Dehradun, offering full-service production from formulation R&D and stability/validation studies to commercial-scale manufacture, and supports regulatory submissions (CTD/ACTD dossiers) for export markets.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Cris Pharma is a pharmaceutical manufacturing company offering a portfolio of generic pharmaceutical formulations consisting of Tablets and Oral Liquids. The tablet product line includes analgesic and anti-inflammatory medications such as Aceclofenac and Paracetamol combinations, while the oral liquid portfolio includes pediatric suspensions, anthelmintic solutions, and respiratory syrups. Beyond product manufacturing, the company provides contract manufacturing services encompassing formulation research and development, stability studies, and validation studies. The company operates a WHO-GMP certified manufacturing facility for both domestic and international markets.

Product and service9 records
1Contract Manufacturing Services
CategoryPharmaceutical Contract Manufacturing
Description

Pharmaceutical contract manufacturing services covering formulation research and development, periodic and accelerated stability studies, validation studies, new method development, and commercial-scale production of Tablets and Liquid Orals for domestic and export markets.

2Aceclofenac and Paracetamol Tablets
CategoryTablet Formulations
Description

Film coated tablets containing Aceclofenac BP 100 mg and Paracetamol BP 325 mg, used as analgesic and anti-inflammatory medication.

3Aceclofenac & Acetaminophen Tablets
CategoryTablet Formulations
Description

Uncoated tablets containing Acetaminophen USP 325 mg, used for pain relief and fever reduction.

4Acetaminophen with Caffeine Tablets USP
CategoryTablet Formulations
Description

Uncoated tablets containing Acetaminophen USP 500 mg and Caffeine USP 65 mg, combining analgesic with stimulant properties.

5Acetaminophen with Phenylephrine Tablets
CategoryTablet Formulations
Description

Uncoated tablets containing Phenylephrine Hydrochloride USP 5 mg, used for cold and sinus relief.

6Acetaminophen Oral Suspension USP (125mg)
CategoryLiquid Orals
Description

Oral suspension containing Acetaminophen USP 125 mg per 5 ml, pediatric formulation for fever and pain relief.

7Acetaminophen Oral Suspension USP (250mg)
CategoryLiquid Orals
Description

Oral suspension containing Acetaminophen USP 250 mg per 5 ml, for fever and pain management.

8Albendazole Suspension
CategoryLiquid Orals
Description

Oral suspension containing Albendazole USP 200 mg per 5 ml, used for parasitic worm infections.

9Ambroxol Hydrochloride & Salbutamol Syrup
CategoryLiquid Orals
Description

Syrup containing Ambroxol Hydrochloride BP 15mg and Salbutamol Sulphate BP 1mg per 5 ml, used as expectorant and bronchodilator.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Oasis Test House Limited
Strategic tierCoreTypeOthers
Description

Group company providing commercial testing laboratories and leading analytical services in India. Located at Ahmedabad and Jaipur, it supports quality assurance and testing capabilities for Cris Pharma's pharmaceutical manufacturing operations.

crispharma.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Indian generic manufacturer with strong presence in Africa and other emerging markets; comparable as an Indian pharma exporter focused on oral solids and semi-regulated markets, including Africa.

TypeBroad incumbent
Description

Major Indian generic manufacturer with significant export operations across Africa, Asia, and regulated markets; comparable as an Indian pharma exporter with strong presence in Nigeria and other African geographies served by Cris Pharma.

TypeBroad incumbent
Description

Large Indian API and contract manufacturer exporting globally with strong regulatory track record; comparable as an Indian pharma exporter with WHO-GMP facilities serving international pharma MNCs, though at much greater scale and API-focused.

4Syngene International
TypeBroad incumbent
Description

Leading Indian CRO/CDMO providing contract research, development, and manufacturing services to global pharma; comparable contract services model serving international pharma clients, broader in scope including biologics and clinical research.

5Recipharm
TypeBroad incumbent
Description

European-headquartered CDMO offering contract manufacturing of oral solids, sterile, and other dosage forms; comparable as a contract manufacturer serving pharma clients across geographies, though primarily focused on regulated markets.

TypeBroad incumbent
Description

Global CDMO leader providing contract manufacturing across multiple dosage forms to pharma and biotech; comparable as a contract manufacturer serving pharma clients with regulatory-grade facilities, though at significantly larger scale and broader scope.

TypeBroad incumbent
Description

Indian pharma services company spanning CDMO, generics, and radiopharma; comparable as an Indian contract manufacturer and exporter with international regulatory approvals and global pharma clients.

TypeBroad incumbent
Description

Large Indian pharma company with global manufacturing footprint and significant Africa/emerging-market presence; comparable as Indian pharma with WHO-GMP facilities and export operations across geographies where Cris Pharma operates.

TypeRegional player
Description

Indian pharmaceutical company with CDMO services and strong emerging-market focus; comparable as an Indian pharma manufacturer and exporter, though with stronger API and ARV focus and broader product portfolio.

TypeDirect peer
Description

Indian-headquartered CDMO offering contract development and manufacturing across multiple dosage forms for global pharma companies; directly comparable as an Indian contract manufacturer serving MNC clients, though at significantly larger scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cris Pharma

Pharmaceutical Contract Manufacturingcrispharma.com

Cris Pharma (India) Limited is a private pharmaceutical contract manufacturer operating a WHO-GMP certified facility in Dehradun that produces generic tablets and liquid orals for leading Indian pharmaceutical MNCs and export markets across Africa and Asia.

What Cris Pharma does

Cris Pharma (India) Limited is a privately held pharmaceutical contract manufacturer founded in 1992 and headquartered in Jaipur, India. The company operates a WHO-GMP certified and ISO 9001:2015 compliant manufacturing facility located in a Special Economic Zone at Selaqui, Dehradun, Uttarakhand, which has been operational since June 2006. Production is concentrated on two dosage formats: tablets (including direct compression, aqueous-coated, enteric-coated, modified/sustained release, dispersible, and bi-layer variants) and liquid orals (oral suspensions and syrups). The in-house quality control laboratory is equipped with HPLC, FTIR, dissolution apparatus, and UV spectrophotometer across physico-chemical, instrumental, microbiological, and packaging material testing sections. The company's product portfolio comprises generic formulations such as Aceclofenac + Paracetamol tablets, Acetaminophen combinations, Albendazole suspension, and Ambroxol + Salbutamol syrup.

The business model is exclusively B2B contract manufacturing (CMO), with no direct-to-consumer sales. Cris Pharma manufactures on behalf of "leading Indian pharmaceutical MNCs" for both domestic distribution and international export, with pricing handled on a quote basis tied to product specifications, volume, and regulatory requirements. Revenue is generated from contract manufacturing fees and export sales to seven countries spanning West Africa (Nigeria, Ivory Coast, Ghana), East Africa (Kenya, Uganda), Southeast Asia (Myanmar), and Central Asia (Uzbekistan). International regulatory affairs capabilities include CTD/ACTD dossier preparation and submission per the requirements of each country's Ministry of Health. Distribution is entirely direct-to-pharma-company (B2B), with no third-party logistics, retail, or e-commerce channels.

The company is managed by four directors (two at the Jaipur corporate office, one technical and one executive director at the Dehradun manufacturing facility) plus dedicated heads of Quality Control and Quality Assurance. It is part of a broader pharmaceutical group that includes Oasis Test House Limited (a leading Indian analytical services provider based in Ahmedabad and Jaipur) and Oasis Infotech (developer of OasisLIMS pharma ERP software), giving the group four decades of pharmaceutical sector experience. The company is privately held with no disclosed external investors, funding rounds, or parent company affiliation, and appears to be founder/management-owned.

Cris Pharma firmographics

Firmographics
Name
Cris Pharma
Legal name
Cris Pharma (India) Limited
Website
https://crispharma.com
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
11–50 employees
Short description
Cris Pharma (India) Limited is a private pharmaceutical contract manufacturer operating a WHO-GMP certified facility in Dehradun that produces generic tablets and liquid orals for leading Indian pharmaceutical MNCs and export markets across Africa and Asia.
Ownership category
akta.pro rank

Where Cris Pharma is headquartered

Location

Headquarters

HQ city
Jaipur
HQ country
India
HQ region
Asia

Offices4 records

Markets served

Cris Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Contract Manufacturing Services: Cris Pharma generates revenue through contract manufacturing pharmaceutical formulations (Tablets and Liquid Orals) for domestic and export markets. The company manufactures products on contract basis for leading pharmaceutical companies, providing full-service manufacturing from process development to commercial scale production.
  2. Export of Manufactured Drugs: Revenue from exporting manufactured pharmaceutical products to international markets including Nigeria, Myanmar, Ghana, Kenya, and Uganda. The company has regulatory approvals in multiple Francophone and African countries.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Cris Pharma product offering

Product offering

Core offering

Cris Pharma is a pharmaceutical contract manufacturer that produces Tablets and Liquid Orals on a P2P basis for leading Indian pharmaceutical companies and international buyers. The company operates a WHO-GMP certified manufacturing facility at SEZ, Dehradun, offering full-service production from formulation R&D and stability/validation studies to commercial-scale manufacture, and supports regulatory submissions (CTD/ACTD dossiers) for export markets.

Product overview

Cris Pharma is a pharmaceutical manufacturing company offering a portfolio of generic pharmaceutical formulations consisting of Tablets and Oral Liquids. The tablet product line includes analgesic and anti-inflammatory medications such as Aceclofenac and Paracetamol combinations, while the oral liquid portfolio includes pediatric suspensions, anthelmintic solutions, and respiratory syrups. Beyond product manufacturing, the company provides contract manufacturing services encompassing formulation research and development, stability studies, and validation studies. The company operates a WHO-GMP certified manufacturing facility for both domestic and international markets.

Differentiator

Problem solved

Functional benefit

Products and services

  • Contract Manufacturing Services Pharmaceutical contract manufacturing services covering formulation research and development, periodic and accelerated stability studies, validation studies, new method development, and commercial-scale production of Tablets and Liquid Orals for domestic and export markets.
  • Aceclofenac and Paracetamol Tablets Film coated tablets containing Aceclofenac BP 100 mg and Paracetamol BP 325 mg, used as analgesic and anti-inflammatory medication.
  • Aceclofenac & Acetaminophen Tablets Uncoated tablets containing Acetaminophen USP 325 mg, used for pain relief and fever reduction.
  • Acetaminophen with Caffeine Tablets USP Uncoated tablets containing Acetaminophen USP 500 mg and Caffeine USP 65 mg, combining analgesic with stimulant properties.
  • Acetaminophen with Phenylephrine Tablets Uncoated tablets containing Phenylephrine Hydrochloride USP 5 mg, used for cold and sinus relief.
  • Acetaminophen Oral Suspension USP (125mg) Oral suspension containing Acetaminophen USP 125 mg per 5 ml, pediatric formulation for fever and pain relief.
  • Acetaminophen Oral Suspension USP (250mg) Oral suspension containing Acetaminophen USP 250 mg per 5 ml, for fever and pain management.
  • Albendazole Suspension Oral suspension containing Albendazole USP 200 mg per 5 ml, used for parasitic worm infections.
  • Ambroxol Hydrochloride & Salbutamol Syrup Syrup containing Ambroxol Hydrochloride BP 15mg and Salbutamol Sulphate BP 1mg per 5 ml, used as expectorant and bronchodilator.

Companies that use Cris Pharma

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Cris Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Cris Pharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Oasis Test House LimitedcoreOthersGroup company providing commercial testing laboratories and leading analytical services in India. Located at Ahmedabad and Jaipur, it supports quality assurance and testing capabilities for Cris Pharma's pharmaceutical manufacturing operations.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Cris Pharma competitors and assessment

Company assessment

Broad incumbents

  • Strides Pharma: Indian generic manufacturer with strong presence in Africa and other emerging markets; comparable as an Indian pharma exporter focused on oral solids and semi-regulated markets, including Africa.
  • Aurobindo Pharma: Major Indian generic manufacturer with significant export operations across Africa, Asia, and regulated markets; comparable as an Indian pharma exporter with strong presence in Nigeria and other African geographies served by Cris Pharma.
  • Divi's Laboratories: Large Indian API and contract manufacturer exporting globally with strong regulatory track record; comparable as an Indian pharma exporter with WHO-GMP facilities serving international pharma MNCs, though at much greater scale and API-focused.
  • Syngene International: Leading Indian CRO/CDMO providing contract research, development, and manufacturing services to global pharma; comparable contract services model serving international pharma clients, broader in scope including biologics and clinical research.
  • Recipharm: European-headquartered CDMO offering contract manufacturing of oral solids, sterile, and other dosage forms; comparable as a contract manufacturer serving pharma clients across geographies, though primarily focused on regulated markets.
  • Lonza Group: Global CDMO leader providing contract manufacturing across multiple dosage forms to pharma and biotech; comparable as a contract manufacturer serving pharma clients with regulatory-grade facilities, though at significantly larger scale and broader scope.
  • Jubilant Pharmova: Indian pharma services company spanning CDMO, generics, and radiopharma; comparable as an Indian contract manufacturer and exporter with international regulatory approvals and global pharma clients.
  • Dr. Reddy's Laboratories: Large Indian pharma company with global manufacturing footprint and significant Africa/emerging-market presence; comparable as Indian pharma with WHO-GMP facilities and export operations across geographies where Cris Pharma operates.

Regional players

  • Laurus Labs: Indian pharmaceutical company with CDMO services and strong emerging-market focus; comparable as an Indian pharma manufacturer and exporter, though with stronger API and ARV focus and broader product portfolio.

Direct peers

  • Piramal Pharma Solutions: Indian-headquartered CDMO offering contract development and manufacturing across multiple dosage forms for global pharma companies; directly comparable as an Indian contract manufacturer serving MNC clients, though at significantly larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

Cris Pharma social profiles

Digital presence

Cris Pharma compliance and trust

Trust signal

Compliance6 records

Cris Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cris Pharma leadership team

Management profile

Number of profiles

Profiles1 record

Cris Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cris Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cris Pharma

What does Cris Pharma do?

Cris Pharma is a pharmaceutical contract manufacturer that produces Tablets and Liquid Orals on a P2P basis for leading Indian pharmaceutical companies and international buyers. The company operates a WHO-GMP certified manufacturing facility at SEZ, Dehradun, offering full-service production from formulation R&D and stability/validation studies to commercial-scale manufacture, and supports regulatory submissions (CTD/ACTD dossiers) for export markets.

Is Cris Pharma a public or private company?

Cris Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Cris Pharma founded?

Cris Pharma was founded in 1992. It employs 11 to 50 people.

Where is Cris Pharma based?

Cris Pharma is headquartered in Jaipur, India, in the Asia region.

How does Cris Pharma make money?

Two revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are export of Manufactured Drugs.

Who are Cris Pharma's main competitors?

Broad incumbents on record are Strides Pharma, Aurobindo Pharma, Divi's Laboratories, Syngene International, Recipharm, Lonza Group, Jubilant Pharmova and Dr. Reddy's Laboratories. Laurus Labs is listed as a regional player. Piramal Pharma Solutions is listed as a direct peer.

Does Cris Pharma have an API?

No public API is recorded for Cris Pharma.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales